Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Tumour Biol ; 35(5): 4983-6, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24453034

RESUMEN

Cancer is a multifactorial disease with a high mortality rate in Brazil and worldwide. Gastric cancer (GC) is considered the fourth type of malignancy more frequent in the population worldwide and the second leading cause of death. This work aimed to evaluate single nucleotide polymorphisms (SNPs) of IFNGR1, GSTT1, and GSTP1 genes samples in gastric cancer. We analyzed 60 samples of gastric cancer, 26 diffuse and 34 intestinal types, totaling 120 alleles for each SNP. The results were obtained by PCR and allele-specific PCR. Statistical analyzes performed using BioEstat 5.0 software, applying the Fisher's exact test and chi-square. Only the SNP gene GSTP1 (rs1695) were significantly associated with gastric cancer in the samples analyzed (χ(2) = 8.73, P < 0.05). Our results suggest that the GSTP1 gene SNP (rs1695) can be considered a risk factor associated with gastric carcinogenesis.


Asunto(s)
Predisposición Genética a la Enfermedad , Gutatión-S-Transferasa pi/genética , Glutatión Transferasa/genética , Polimorfismo de Nucleótido Simple , Receptores de Interferón/genética , Neoplasias Gástricas/genética , Brasil , Humanos , Neoplasias Gástricas/etiología , Receptor de Interferón gamma
2.
BMC Gastroenterol ; 12: 85, 2012 Jul 06.
Artículo en Inglés | MEDLINE | ID: mdl-22768805

RESUMEN

BACKGROUND: Gastric cancer is a serious public health problem in Northern Brazil and in the world due to its high incidence and mortality. Despite the severity of the disease, more research is needed to better understand the molecular events involved in this intestinal-type gastric carcinogenesis process. Since precancerous lesions precede intestinal-type gastric cancer, here, we evaluated the hTERT, MYC, and TP53 mRNA and protein expression, as well as TP33 copy number, in gastric preneoplastic lesions. METHODS: We evaluated 19 superficial gastritis, 18 atrophic gastritis, and 18 intestinal metaplasia from cancer-free individuals of Northern Brazil. Quantitative reverse transcription PCR was used to analyze the mRNA expression and immunohistochemical methods were used to assess protein immunoreactivity in tissue samples. The number of TP53 gene copies was investigated in gastric diseases by quantitative PCR. RESULTS: We observed hTERT, MYC, and p53 immunoreactivity only in intestinal metaplasia samples. The immunoreactivity of these proteins was strongly associated with each other. A significantly higher MYC mRNA expression was observed in intestinal metaplasia compared to gastritis samples. Loss of TP53 was also only detected in intestinal metaplasia specimens. CONCLUSIONS: We demonstrated that hTERT, MYC, and TP53 are deregulated in intestinal metaplasia of individuals from Northern Brazil and these alterations may facilitate tumor initiation.


Asunto(s)
Lesiones Precancerosas/metabolismo , Proteínas Proto-Oncogénicas c-myc/metabolismo , Neoplasias Gástricas/metabolismo , Telomerasa/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Brasil , Transformación Celular Neoplásica/metabolismo , Femenino , Gastritis/genética , Gastritis/metabolismo , Dosificación de Gen , Regulación Neoplásica de la Expresión Génica/genética , Regulación Neoplásica de la Expresión Génica/fisiología , Humanos , Inmunohistoquímica , Masculino , Metaplasia/genética , Metaplasia/metabolismo , Lesiones Precancerosas/genética , Lesiones Precancerosas/patología , Proteínas Proto-Oncogénicas c-myc/análisis , Neoplasias Gástricas/genética , Neoplasias Gástricas/patología , Telomerasa/análisis , Proteína p53 Supresora de Tumor/análisis , Proteína p53 Supresora de Tumor/genética
3.
Homeopathy ; 101(1): 74-9, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22226318

RESUMEN

INTRODUCTION: Canova is a complex homeopathic medicine that enhances a specific immunologic responses against several exogenous and endogenous conditions. Canova activates macrophages both in vivo and in vitro. AIM AND METHOD: We evaluated the effects of macrophages activated by Canova in vivo and ex vitro in the proliferation of lymphocytes. Canova was used to activate Cebus apella macrophages in vivo or ex vitro with Canova. Lymphocytes were cultured with the macrophage culture medium. The analysis of Canova effects in cultured lymphocytes was performed according to the cell cycle phase using flow cytometry. The Interferon gamma and Interleukin-5 cytokines quantification in these lymphocyte culture media was performed by Enzyme-linked immunosorbent assay (ELISA). RESULTS: We observed that Canova actives macrophages in vivo and ex vitro. The lymphocytes cultured in a supplemented medium with macrophages activated by Canova treatment presented a higher number of proliferation cells than lymphocytes not exposed to macrophages activated by Canova. The Interferon gamma and Interleukin-5 cytokines were only observed in the medium of lymphocytes exposed to macrophages activated by Canova. Thus, Canova has potential as a new adjuvant therapy.


Asunto(s)
Cebus , Factores Inmunológicos/farmacología , Activación de Linfocitos/efectos de los fármacos , Macrófagos , Animales , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Homeopatía , Interferón gamma/metabolismo , Interleucina-5/metabolismo , Masculino , Distribución Aleatoria , Resultado del Tratamiento
4.
J Biomed Biotechnol ; 2011: 631268, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21528007

RESUMEN

We evaluated whether MYC, TP53, and chromosome 17 copy-number alterations occur in ACP02, ACP03, and AGP01 gastric cancer cell lines and in their tumor counterpart. Fluorescence in situ hybridization for MYC and TP53 genes and for chromosome 17 was applied in the 6th, 12th, 60th, and 85th passages of the cell lines and in their parental primary tumors. We observed that three and four MYC signals were the most common alterations in gastric cell lines and tumors. ACP02 presented cells with two copies of chr17 and loss of one copy of TP53 more frequently than ACP03 and AGP01. Only ACP03 and AGP01 presented clonal chr17 trisomy with three or two TP53 copies. The frequency of MYC gain, TP53 loss, and chromosome 17 trisomy seems to increase in gastric cell lines compared to their parental tumors. Our findings reveal that these cell lines retain, in vitro, the genetic alterations presented in their parental primary tumors.


Asunto(s)
Aberraciones Cromosómicas , Cromosomas Humanos Par 17/genética , Proteínas Proto-Oncogénicas c-myc/genética , Neoplasias Gástricas/genética , Proteína p53 Supresora de Tumor/genética , Línea Celular Tumoral , Dosificación de Gen , Humanos , Hibridación Fluorescente in Situ
5.
J Gastrointest Cancer ; 52(2): 625-633, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32583363

RESUMEN

PURPOSE: Analyze the expression of caspase-9, Smac/DIABLO, XIAP, let-7a, and let-7b in patients with normal gastric tissue, chronic gastritis, and gastric adenocarcinoma. METHODS: The expression of caspase-9, Smac/DIABLO, XIAP, let-7a, and let-7b by qRT-PCR was analyzed in 158 samples from 53 patients with normal gastric mucosa, 86 with chronic gastritis, and 19 with gastric cancer. RESULTS: The comparison between the gastric cancer and the control group revealed a decreased expression of caspase-9 in gastric cancer tissues; considering the Helicobacter pylor presence, comparable results were revealed. Smac/DIABLO was increased in gastric cancer cells, while XIAP demonstrated no significant difference in the gene expression. The microRNA analysis revealed a decreased expression of let-7a and let-7b in samples positive to H. pylori infection and in gastric cancer group, regardless of the presence of the bacterium. CONCLUSION: Our study provided some evidence of low activity of the intrinsic apoptosis pathway, as well as the influence of H. pylori on let-7a and let-7b expression.


Asunto(s)
Adenocarcinoma/genética , Apoptosis/genética , Biomarcadores de Tumor/genética , Carcinogénesis/genética , Neoplasias Gástricas/genética , Adenocarcinoma/patología , Adulto , Anciano , Proteínas Reguladoras de la Apoptosis/genética , Biopsia , Caspasa 9/genética , Femenino , Mucosa Gástrica/microbiología , Mucosa Gástrica/patología , Gastritis/genética , Gastritis/microbiología , Gastritis/patología , Perfilación de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Infecciones por Helicobacter/genética , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/patología , Helicobacter pylori/aislamiento & purificación , Humanos , Masculino , MicroARNs/genética , Persona de Mediana Edad , Proteínas Mitocondriales/genética , Neoplasias Gástricas/microbiología , Neoplasias Gástricas/patología , Proteína Inhibidora de la Apoptosis Ligada a X/genética
6.
In Vivo ; 24(3): 281-6, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20554999

RESUMEN

The identification of cytogenetic abnormalities in schizophrenic patients may provide clues to the genes involved in this disease. For this reason, a chromosomal analysis of samples from 62 schizophrenics and 70 controls was performed with trypsin-Giemsa banding and fluorescence in situ hybridization of the X chromosome. A clonal pericentric inversion on chromosome 9 was detected in one male patient, and we also discovered mosaicism associated with X chromosome aneuploidy in female patients, primarily detected in schizophrenic and normal female controls over 40 years old. When compared with age-matched female controls, the frequency of X chromosome loss was not significantly different between schizophrenics and controls, except for the 40- to 49-year-old age group. Our findings suggest that the X chromosome loss seen in schizophrenic patients is inherent to the normal cellular aging process. However, our data also suggest that X chromosome gain may be correlated with schizophrenia in this Brazilian population.


Asunto(s)
Aberraciones Cromosómicas , Cromosomas Humanos X/genética , Esquizofrenia/genética , Adulto , Anciano , Envejecimiento/genética , Aneuploidia , Brasil , Femenino , Humanos , Hibridación Fluorescente in Situ , Linfocitos/fisiología , Masculino , Persona de Mediana Edad , Mosaicismo
7.
Cancer Genet Cytogenet ; 181(1): 31-5, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18262050

RESUMEN

Gastric cancer is the second leading cause of death by cancer in Brazil. Early gastric cancer represents approximately 10% of gastric cancer cases in some services of Brazil, which underscores the need for early gastric cancer diagnosis that could lead to better prognosis. There are few published studies of cytogenetic alterations in early gastric cancer. To evaluate MYC copy number and its protein expression, we performed fluorescence in situ hybridization and immunohistochemical analyses in five early gastric adenocarcinomas in individuals from northern Brazil. Three signals of MYC and MYC immunoreactivity were observed in all five samples, regardless of histologic type, tumor extension, or lymph nodal status. These novel findings concerning MYC copy number alteration in early gastric cancer suggest that MYC alteration is observed in the beginning of gastric carcinogenesis and could be used as a therapeutic target.


Asunto(s)
Adenocarcinoma/genética , Aberraciones Cromosómicas , Genes myc , Neoplasias Gástricas/genética , Adenocarcinoma/patología , Adulto , Anciano , Brasil , Femenino , Amplificación de Genes , Humanos , Hibridación Fluorescente in Situ , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Estadificación de Neoplasias , Neoplasias Gástricas/patología
9.
J Gastrointest Cancer ; 49(1): 97-101, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29243018

RESUMEN

PURPOSE: This study investigated miRNA-181c expression in control patients (healthy gastric mucosa), patients with gastritis, and patients with gastric cancer. The presence of Helicobacter pylori was determined, and the associations between H. pylori infection, levels of miRNA-181c expression, and gastric disease were also analyzed. METHODS: A total of 158 subjects were included in the study, and the three groups were respectively composed of 53 controls, 86 patients with gastritis, and 19 patients with gastric cancer. miRNA-181c expression and H. pylori infection were determined by quantitative real-time PCR and PCR, respectively. The subsequent target gene analysis was performed using the bioinformatics approach to understand the possible mechanisms of gastric cancer. RESULTS: We determined significantly lower miRNA-181c expression in the gastric cancer group when compared to the control and gastritis groups, regardless of the presence of H. pylori. There was no difference in miRNA-181c expression between the control group and gastritis group, whether the presence of H. pylori was considered or not. The bioinformatics approach identified several genes as possible targets for miRNA-181c, including the X-linked inhibitor of apoptosis (XIAP) gene (which encodes a protein that belongs to a family of apoptotic suppressor proteins), the caspase 9 gene, and the caspase 3 gene. All target genes identified may be involved in gastric cancer and apoptosis pathways. CONCLUSION: The results suggest that the presence of H. pylori has no influence on microRNA expression and that the downregulation of miR-181c may play an important role in gastric cancer progression by controlling important genes associated with apoptosis. Therefore, miRNA-181c may be a potential marker of gastric cancer.


Asunto(s)
MicroARNs/biosíntesis , Neoplasias Gástricas/genética , Apoptosis/genética , Estudios de Casos y Controles , Infecciones por Helicobacter/genética , Infecciones por Helicobacter/metabolismo , Humanos , MicroARNs/genética , MicroARNs/metabolismo , Neoplasias Gástricas/microbiología , Neoplasias Gástricas/patología
10.
Toxicol In Vitro ; 50: 225-235, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29574239

RESUMEN

Malignant melanoma is an important type of cancer worldwide due to its aggressiveness and poor survival rate. Significant efforts to understand the biology of melanoma and approaches to treat the advanced disease are focused on targeted gene inhibitors. Frequently mutated genes, such as NRAS, B-RAF and TP53, significantly exceed the frequency of mutations of other genes, emphasizing their importance for future targeted therapies. Considering the antitumor activity of benzothiazolic derivatives, this study aimed to demonstrate the action of benzothiazolic (E)-2-((2-(benzo[d]thiazol-2-yl)hydrazono)methyl)-4-nitrophenol (AFN01) against three established human melanoma cell lines that recapitulate the molecular landscape of the disease in terms of its genetic alterations and mutations, such as the TP53, NRAS and B-RAF genes. The results presented here indicate that AFN01, as a significant cytostatic and cytotoxic drug due to its induction of DNA fragmentation, causes single and double DNA strand breaks, consequently inhibiting cell proliferation, migration and invasion by promoting apoptosis. Our data suggest that AFN01 might be considered as a future therapeutic option for managing melanoma.


Asunto(s)
Antineoplásicos/farmacología , Hidrazonas/farmacología , Nitrofenoles/farmacología , Tiazoles/farmacología , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Fragmentación del ADN , GTP Fosfohidrolasas/genética , Humanos , Melanoma/tratamiento farmacológico , Melanoma/genética , Proteínas de la Membrana/genética , Proteínas Proto-Oncogénicas B-raf/genética , Proteína p53 Supresora de Tumor/genética , Cicatrización de Heridas/efectos de los fármacos
11.
Cancer Genet Cytogenet ; 179(1): 45-51, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17981214

RESUMEN

Numerical alterations of chromosome 9, the status of promoter methylation and protein expression of the CDKN2A gene (aliases include p16 and p16(INK4a)), the possible association with gain of chromosome X, and the interrelation of these findings with clinic and pathological characteristics were investigated in gastric adenocarcinomas. Fluorescence in situ hybridization analysis with centromeric DNA probes, immunohistochemical staining, and methylation-specific polymerase chain reaction assays were performed in 15 gastric adenocarcinomas samples from individuals from northern Brazil. Aneuploidies of chromosomes X and 9 were found in all samples, both intestinal and diffuse type. Monosomy of chromosome 9 and gain of a copy of chromosome X (in both sexes) were observed in 100% of cases. Hypermethylation frequency and protein expression of CDKN2A were also found in all cases analyzed. No association of genetic and epigenetic alterations with histological type, tumor aggressiveness, and invasion was found (P > 0.05), which may be attributable to small sample size. There was a high level of association between absence of p16 protein expression levels, CDKN2A gene promote hypermethylation, and chromosome 9 aneuploidy (100% of cases). Thus, in the present samples, the apparent mechanisms behind p16 silencing include loss of chromosome 9 and promoter region hypermethylation.


Asunto(s)
Adenocarcinoma/genética , Aneuploidia , Inhibidor p16 de la Quinasa Dependiente de Ciclina/genética , Metilación de ADN , Genes p16 , Regiones Promotoras Genéticas , Neoplasias Gástricas/genética , Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Adulto , Anciano , Cromosomas Humanos Par 9 , Cromosomas Humanos X , Inhibidor p16 de la Quinasa Dependiente de Ciclina/metabolismo , Femenino , Humanos , Hibridación Fluorescente in Situ , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patología
12.
Arch Med Res ; 38(5): 551-5, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17560462

RESUMEN

BACKGROUND: The discovery of Helicobacter pylori offered the etiologic agent of the initiating event of the inflammatory cascade. It has been confirmed that the development of gastric cancer spans over several decades sequentially starting with the acquisition of H. pylori infection and the development of chronic gastritis. The IL-6 gene (Il-6), inflammatory cytokine and the single-nucleotide polymorphisms (SNPs) at the 5' flanking region of the Il-6 gene promoter (G or C at -174 base and at -572 or -597 C or A) have been identified with increased Il-6 levels. METHODS: Biopsies were collected from 168 patients. SNPs in Il-6-174 were analyzed by PCR-RFLP. RESULTS: Promoter SNP of Il-6 at -174 base were within Hardy-Weinberg equilibrium. We did not find any association between the frequencies of -174 polymorphism with specific histological type of gastric adenocarcinoma, but the G (guanine) allele at -174 was significantly higher in gastric adenocarcinoma than in patients with chronic gastritis. CONCLUSIONS: We observed an association between GG allele on -174 base with gastric cancer.


Asunto(s)
Adenocarcinoma/genética , Gastritis/genética , Infecciones por Helicobacter/complicaciones , Helicobacter pylori/aislamiento & purificación , Interleucina-6/genética , Polimorfismo de Nucleótido Simple , Neoplasias Gástricas/genética , Adenocarcinoma/complicaciones , Adenocarcinoma/microbiología , Adenocarcinoma/patología , Brasil , Enfermedad Crónica , Femenino , Gastritis/complicaciones , Gastritis/microbiología , Predisposición Genética a la Enfermedad , Infecciones por Helicobacter/microbiología , Helicobacter pylori/patogenicidad , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Neoplasias Gástricas/complicaciones , Neoplasias Gástricas/microbiología , Neoplasias Gástricas/patología
13.
J Alzheimers Dis ; 10(4): 365-9, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17183147

RESUMEN

Alzheimer's disease (AD) is the most common neurodegenerative disorder in the elderly and is also considered a progeroid genetic syndrome. The etiology of AD is complex and the mechanisms underlying its pathophysiology remain to be clarified. It has been suggested that a high serum cholesterol level is a risk factor for (AD), and that some polymorphisms of genes encoding proteins regulating cholesterol metabolism are associated with AD development. APOA5 is a recently discovered apolipoprotein involved primarily with triglyceride (TG) metabolism disorder. This study investigates the association of AD with the APOA5 gene -1131T>C polymorphisms in samples of 106 patients with Alzheimer's disease (AD), 76 elderly healthy controls and 93 young healthy controls. DNA samples were isolated from blood cells, amplified by PCR and digested with Tru1l. We observed that the genotype distributions of APOA5 variants were within Hardy-Weinberg equilibrium in all subject samples. Furthermore, chi-square test comparison for genotype distributions and allele frequencies did not reveal any significant difference among the three groups of subjects P>0.05). These results support the idea that these variants are not involved as a risk factor for developing AD.


Asunto(s)
Enfermedad de Alzheimer/genética , Apolipoproteínas A/genética , Polimorfismo Genético/genética , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/fisiopatología , Apolipoproteína A-V , Femenino , Frecuencia de los Genes/genética , Tamización de Portadores Genéticos , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Valores de Referencia , Factores de Riesgo , Triglicéridos/sangre
14.
Anticancer Res ; 26(4B): 2909-14, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16886612

RESUMEN

BACKGROUND: The genetic events involved in gastric cancer, the third most frequent cancer in the world with a high incidence in Pard State, Brazil, remain largely unknown. MATERIALS AND METHODS: Twenty-one primary gastric adenocarcinomas were investigated by comparative genomic hybridization (CGH) and the relationships between genomic abnormalities and histopathological features were evaluated. RESULTS: Eighty-one percent of cases presented DNA copy-number changes. Chromosomal gains were the most frequent finding, losses occurring only in the diffuse type. The main copy-number gains were on chromosome 8, principally on 8q24.1 (8/21 cases), 8p21 (3/21) and 8p23.2-8p12 (2/21). Gain of region 8q24. 1, where C-MYC is located, was the main finding, exclusively in the intestinal type with metastasis. CONCLUSION: C-MYC locus amplification may be predictor of aggressiveness in intestinal-type gastric cancer, playing an important role in its development and progression. Moreover, other genes on 8q24 should be investigated. Gastric adenocarcinomas of differing histopathological features were associated with distinct genetic alterations, supporting the hypothesis that they evolve through distinct genetic pathways.


Asunto(s)
Adenocarcinoma/genética , Aberraciones Cromosómicas , Genes myc , Neoplasias Gástricas/genética , Adenocarcinoma/patología , Adulto , Anciano , Amplificación de Genes , Dosificación de Gen , Humanos , Persona de Mediana Edad , Metástasis de la Neoplasia , Estadificación de Neoplasias , Hibridación de Ácido Nucleico , Neoplasias Gástricas/patología
15.
World J Gastroenterol ; 12(38): 6207-11, 2006 Oct 14.
Artículo en Inglés | MEDLINE | ID: mdl-17036397

RESUMEN

AIM: To investigate chromosome 8 numerical aberrations, C-MYC oncogene alterations and its expression in gastric cancer and to correlate these findings with histopathological characteristics of gastric tumors. METHODS: Specimens were collected surgically from seven patients with gastric adenocarcinomas. Immunostaining for C-MYC and dual-color fluorescence in situ hybridization (FISH) for C-MYC gene and chromosome 8 centromere were performed. RESULTS: All the cases showed chromosome 8 aneuploidy and C-MYC amplification, in both the diffuse and intestinal histopathological types of Lauren. No significant difference (P < 0.05) was observed between the level of chromosome 8 ploidy and the site, stage or histological type of the adenocarcinomas. C-MYC high amplification, like homogeneously stained regions (HSRs) and double minutes (DMs), was observed only in the intestinal-type. Structural rearrangement of C-MYC, like translocation, was observed only in the diffuse type. Regarding C-MYC gene, a significant difference (P < 0.05) was observed between the two histological types. The C-MYC protein was expressed in all the studied cases. In the intestinal-type the C-MYC immunoreactivity was localized only in the nucleus and in the diffuse type in the nucleus and cytoplasm. CONCLUSION: Distinct patterns of alterations between intestinal and diffuse types of gastric tumors support the hypothesis that these types follow different genetic pathways.


Asunto(s)
Adenocarcinoma/genética , Cromosomas Humanos Par 8 , Genes myc , Neoplasias Gástricas/genética , Adulto , Anciano , Aneuploidia , Brasil , Amplificación de Genes , Regulación Neoplásica de la Expresión Génica , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Persona de Mediana Edad
16.
Toxicol In Vitro ; 34: 237-245, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27079618

RESUMEN

Cancer is a public health problem and the second leading cause of death worldwide. The incidence of cutaneous melanoma has been notably increasing, resulting in high aggressiveness and poor survival rates. Taking into account the antitumor activity of biflorin, a substance isolated from Capraria biflora L. roots that is cytotoxic in vitro and in vivo, this study aimed to demonstrate the action of biflorin against three established human melanoma cell lines that recapitulate the molecular landscape of the disease in terms of genetic alterations and mutations, such as the TP53, NRAS and BRAF genes. The results presented here indicate that biflorin reduces the viability of melanoma cell lines by DNA interactions. Biflorin causes single and double DNA strand breaks, consequently inhibiting cell cycle progression, replication and DNA repair and promoting apoptosis. Our data suggest that biflorin could be considered as a future therapeutic option for managing melanoma.


Asunto(s)
ADN/metabolismo , Melanoma/genética , Naftoquinonas/toxicidad , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Metilasas de Modificación del ADN/genética , Enzimas Reparadoras del ADN/genética , GTP Fosfohidrolasas/genética , Humanos , Proteínas de la Membrana/genética , Mutación , Proteínas Serina-Treonina Quinasas/genética , Proteínas Proto-Oncogénicas B-raf/genética , Timidilato Sintasa/genética , Proteína p53 Supresora de Tumor/genética , Proteínas Supresoras de Tumor/genética , Proteínas ras/genética
17.
Gastroenterol Res Pract ; 2016: 9797410, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-28115929

RESUMEN

Biliary tract cancers are aggressive malignancies that include gallbladder cancer and tumors of intra- and extrahepatic ducts and have a poor prognosis. Surgical resection remains the main curative therapy. Nevertheless, numerous patients experience recurrence even after radical surgery. This scenario drives the research to identify biliary tract cancer biomarkers despite the limited progress that has been made. Recently, a large number of studies have demonstrated that deregulated expression of microRNAs is closely associated with cancer development and progression. In this review, we highlight the role and importance of microRNAs in biliary tract cancers with an emphasis on utilizing circulating microRNAs as potential biomarkers. Additionally, we report several single-nucleotide polymorphisms in microRNA genes that are associated with the susceptibility of biliary tract tumors.

18.
Methods Mol Biol ; 1238: 79-101, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25421656

RESUMEN

Gastric cancer (GC) remains a major cause of mortality despite declining rate in the world. Epigenetic alterations contribute significantly to the development and progression of gastric tumors. Epigenetic refers to the number of modifications of the chromatin structure that affect gene expression without altering the primary sequence of DNA, and these changes lead to transcriptional activation or silencing of the gene. Over the years, the study of epigenetic processes has increased, and novel therapeutic approaches have emerged. This chapter summarizes the main epigenomic mechanisms described recently involved in gastric carcinogenesis, focusing on the roles that aberrant DNA methylation, histone modifications (histone acetylation and methylation), and miRNAs (oncogenic and tumor suppressor function of miRNA) play in the onset and progression of gastric tumors. Clinical implications of these epigenetic alterations in GC are also discussed.


Asunto(s)
Epigénesis Genética , Epigenómica/métodos , Neoplasias Gástricas/genética , Metilación de ADN , Histonas/genética , Humanos , MicroARNs/genética
19.
Artículo en Inglés | MEDLINE | ID: mdl-26719751

RESUMEN

BACKGROUND: Tumor necrosis factor plays a critical role in the pathogenesis of gastric diseases such as gastric cancer, and an abnormal inflammatory response has frequently been observed in dyspeptic patients. Helicobacter pylori infection can induce a gastric mucosal inflammatory response that may be influenced by -308 (G > A) polymorphisms and gene expression of the TNF-α gene. METHODS: One hundred and thirty-four gastric biopsy samples were collected from patients of both genders (61♂ and 73♀, mean age 40.3 ± 24.2 years) with gastric symptoms. The -308 (G > A) polymorphism of TNF-α was characterized using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP). The expression level was measured using real-time PCR, and relative quantification (RQ) was calculated using the comparative CT method (2(-ΔΔCT)). RESULTS: The analysis revealed an increase in TNF-α gene expression in patients with gastritis; on the other hand, no statistical differences were observed in patients with gastric cancer. In addition, no association was found among -308 polymorphism genotypes, virulence markers, or TNF-α gene expression. CONCLUSIONS: Helicobacter pylori induces a large increase in TNF-α expression in patients with gastritis, regardless of tissue inflammation, but after the tissue becomes neoplastic, the presence of bacteria did not influence expression. These results suggest that the TNF-α pathway may play an important role in the progression from gastritis to gastric cancer.

20.
J Oral Sci ; 46(3): 171-7, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15508750

RESUMEN

Progressive chromosome 21 loss in individuals with trisomy 21 or Down syndrome (DS) is supposedly related to their premature senescence. In addition, the telomere hypothesis of cellular aging involving telomere shortening in normal and accelerated aging in vivo and in vitro is well documented. This study investigated the integrity of two chromosome 21 regions (the 21q telomere and the 21q22.13-q22.2 region) and their relationship with aging by means of fluorescence in situ hybridization (FISH) in lymphocytes and gingival fibroblasts cells. The use of tissues from different germ layers allows detection of mosaicism. Chromosome variations in tissue from the neuroectoderm layer could explain the variable phenotype of DS. This approach is original in the literature. Lymphocyte and gingival fibroblast nuclei from 18 affected individuals aged 5-54 years were analyzed. Although not significant (P = 0.06), analysis from 11 tissue-matched individuals as well as the comparison between lymphocytes and fibroblasts from different subjects (P = 0.05) suggested that lymphocyte cells are more likely to miss 21q telomere signals. Hence, gingival fibroblasts are probably capable of more efficient cell repair, and the occurrence of mosaicism is more related to cell proliferation than to germ layer origin. Investigation of the 21q22.13-q22.2 region from six tissue-matched individuals and from different DS patients revealed no significant differences between the tissues.


Asunto(s)
Senescencia Celular/genética , Cromosomas Humanos Par 21/genética , Síndrome de Down/genética , Fibroblastos/diagnóstico por imagen , Linfocitos/ultraestructura , Telómero/genética , Adolescente , Adulto , Niño , Preescolar , Humanos , Modelos Lineales , Persona de Mediana Edad , Estadísticas no Paramétricas , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA